UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Cancer cell, 2016-01, Vol.29 (1), p.49-60

2016

Link zum Volltext

Verfügbarkeit prüfen

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

PloS one, 2019-01, Vol.14 (1), p.e0210608

2019

Link zum Volltext

Verfügbarkeit prüfen

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Clinical cancer research, 2006-09, Vol.12 (17), p.5064-5073

2006

Link zum Volltext

Verfügbarkeit prüfen

Reversing the Warburg Effect as a Treatment for Glioblastoma

The Journal of biological chemistry, 2013-03, Vol.288 (13), p.9153-9164

2013

Link zum Volltext

Verfügbarkeit prüfen

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

The Journal of neuroscience, 2007-10, Vol.27 (42), p.11214-11227

2007

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.101-112

2005

Link zum Volltext

Verfügbarkeit prüfen

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft

Molecular cancer therapeutics, 2005-09, Vol.4 (9), p.1364-1368

2005

Link zum Volltext

Verfügbarkeit prüfen

Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Clinical cancer research, 2002-11, Vol.8 (11), p.3496-3502

2002

Link zum Volltext

Verfügbarkeit prüfen

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Clinical cancer research, 2005-11, Vol.11 (22), p.8145-8157

2005

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells

The Journal of biological chemistry, 2015-12, Vol.290 (52), p.30866-30878

2015

Link zum Volltext

Verfügbarkeit prüfen

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival

Neuro-oncology (Charlottesville, Va.), 2017-09, Vol.19 (9), p.1217-1227

2017

Link zum Volltext

Verfügbarkeit prüfen

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models

Oncotarget, 2016-11, Vol.7 (48), p.79828-79841

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

International journal of cancer, 2000-12, Vol.88 (6), p.962-969

2000

Link zum Volltext

Verfügbarkeit prüfen

Proteomic profiling of patient‐derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development

Journal of neurochemistry, 2015-06, Vol.133 (5), p.730-738

2015

Link zum Volltext

Verfügbarkeit prüfen

Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors

Anti-cancer agents in medicinal chemistry, 2011-02, Vol.11 (2), p.202

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3862-3872

2000

Link zum Volltext

Verfügbarkeit prüfen

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Nuclear medicine and biology, 2010-10, Vol.37 (7), p.741-750

2010

Link zum Volltext

Verfügbarkeit prüfen

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Nuclear medicine and biology, 2006, Vol.33 (1), p.101-110

2006

Link zum Volltext

Verfügbarkeit prüfen

Activity of VNP40101M (Cloretazine) in the treatment of CNS tumor xenografts in athymic mice

Neuro-oncology (Charlottesville, Va.), 2007-07, Vol.9 (3), p.240-244

2007

Link zum Volltext

Verfügbarkeit prüfen

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Clinical cancer research, 1999-09, Vol.5 (9), p.2646-2652

1999

Link zum Volltext

Verfügbarkeit prüfen

Positively charged templates for labeling internalizing antibodies : comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR

Nuclear medicine and biology, 2001-10, Vol.28 (7), p.769-777

2001

Link zum Volltext

Verfügbarkeit prüfen

Preparation and Characterization of Anti-Tenascin Monoclonal Antibody−Streptavidin Conjugates for Pretargeting Applications

Bioconjugate chemistry, 1999-09, Vol.10 (5), p.867-876

1999

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.127-137

1994

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of Lacto Series Gangliosides 3ʼ-isoLM1 and 3ʼ,6ʼ-isoLD1 in Human Gliomas in vitro and in vivo

Journal of neuropathology and experimental neurology, 1991-11, Vol.50 (6), p.756-769

1991

Link zum Volltext

Verfügbarkeit prüfen

Growth and Chemotherapeutic Response in Athymic Mice of Tumors Arising from Human Glioma-derived Cell Lines

Journal of neuropathology and experimental neurology, 1981-07, Vol.40 (4), p.410-427

1981

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionAmerican Association for the Advancement of Science

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Zeitschrift / SerieCancer Research

ThemaTumors Of The Nervous System. Phacomatoses

ThemaMice, Nude

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Reversing the Warburg Effect as a Treatment for Glioblastoma

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft

Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

Proteomic profiling of patient‐derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development

Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Activity of VNP40101M (Cloretazine) in the treatment of CNS tumor xenografts in athymic mice

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Positively charged templates for labeling internalizing antibodies : comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR

Preparation and Characterization of Anti-Tenascin Monoclonal Antibody−Streptavidin Conjugates for Pretargeting Applications

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Occurrence of Lacto Series Gangliosides 3ʼ-isoLM1 and 3ʼ,6ʼ-isoLD1 in Human Gliomas in vitro and in vivo

Growth and Chemotherapeutic Response in Athymic Mice of Tumors Arising from Human Glioma-derived Cell Lines

Aktive Filter

Suchergebnisse filtern